Human Phospho-EGFR (Y845) Antibody AF3394 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman Phospho-EGFR (Y845) Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price $399.00Supplier Page View Company Product Page
Catalog NumberAF3394
ApplicationsImmunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Intracellular Staining by Flow Cytometry,Immunocytochemistry,CyTOF-ready
Conjugate/TagUnconjugated
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
TargetEGFR
Quantity50 ug (also 25 ug)
IsotypeIgG
ReactivityHuman
HostRabbit
ClonalityPolyclonal
Modificationsp tyr845
ImmunogenPhosphopeptide containing human EGFR Y845 site
ConcentrationLYOPH
PurityAntigen Affinity-purified
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Full Gene Nameepidermal growth factor receptor
NCBI Gene AliasesERBB, ERBB1, ERRP, HER1, NISBD2, PIG61, mENA

Available conjugates: Unconjugated

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)GenesOctober 23, 2021Sirinian C, Papanastasiou AD, Degn SE, Frantzi T, Aronis C, Chaniotis D, Makatsoris T, Koutras A, Kalofonos HP.

(2) Comparative Study of Different Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors Affecting Lung Cancer Cell Lines Stably Overexpressing EGFR MutationsBPB ReportsJanuary 1, 2021Tomohiro Ariyama, Yuichiro Kanno, Sonomi Takizawa, Kiyomitsu Nemoto, Toshihiro Ishii(phospho Y1173) (AF1095) (1:2,000 dilution; R&D Systems, Minneapolis, MN, USA), EGFR (phospho Y845) (AF3394) (1:2,000 dilution; R&D systems), EGFR (MI-12-1) (1:4,000 dilution; MBL, Nagoya, Japan), phospho-extracellular

(3) "A nongenomic mechanism for ""metalloestrogenic"" effects of cadmium in human uterine leiomyoma cells through G protein-coupled estrogen receptor"Archives of toxicologyOctober 1, 2019Liu J, Yu L, Castro L, Yan Y, Sifre MI, Bortner CD, Dixon D.antibodies were anti-phospho-Src antibody and anti-phospho-EGFR antibody (Y845) (1:400, catalog no. AF3394, R&D). The density of the respective bands was quantitated using a densitometer with AlphaView Software

(4) Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 ExpressionInternational journal of molecular sciencesFebruary 28, 2013Weissenbacher T, Vrekoussis T, Roeder D, Makrigiannakis A, Mayr D, Ditsch N, Friese K, Jeschke U, Dian D.

(5) Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcomaCancer researchSeptember 15, 2010Dewaele B, Floris G, Finalet-Ferreiro J, Fletcher CD, Coindre JM, Guillou L, Hogendoorn PC, Wozniak A, Vanspauwen V, Schöffski P, et al.

Phospho-EGFR (Y845) Antibody